99 related articles for article (PubMed ID: 5146723)
1. [Metabolism of the ischemic myocardium].
Moret PR
Ann Cardiol Angeiol (Paris); 1971; 20(6):691-7. PubMed ID: 5146723
[No Abstract] [Full Text] [Related]
2. [Drug treatment of chronic coronary disease].
Halawa B
Wiad Lek; 1980 Jan; 33(2):107-11. PubMed ID: 6768197
[No Abstract] [Full Text] [Related]
3. [Underlying mechanism of favorable effect of Ca++-antagonists on conduction delay observed in ischemic myocardium (author's transl)].
Nakaya H
Hokkaido Igaku Zasshi; 1981 May; 56(3):335-45. PubMed ID: 7319455
[TBL] [Abstract][Full Text] [Related]
4. [Combined effect of strophanthin and vasodilator agents on collateral circulation and oxygen tension in the ischemic myocardium].
Sapozhkov AV
Farmakol Toksikol; 1969; 32(4):418-21. PubMed ID: 5357459
[No Abstract] [Full Text] [Related]
5. [Possibilities of differential treatment of the chronic form of ischemic heart disease].
Miasnikov LA; Metelitsa VI
Ter Arkh; 1973; 45(6):8-21. PubMed ID: 4148246
[No Abstract] [Full Text] [Related]
6. [Experimental study of binding and effects of cardiac glycosides in the coronary circulation of the intact and ischemic heart].
Sótonyi P; Juhász Nagy S
Orv Hetil; 1987 Nov; 128(46):2403-7. PubMed ID: 3684258
[No Abstract] [Full Text] [Related]
7. [Problem of increasing the viability of the ischemic myocardium in the light of experimental studies].
Gatsura VV
Kardiologiia; 1975 Feb; 15(2):114-24. PubMed ID: 235663
[TBL] [Abstract][Full Text] [Related]
8. Clinical benefits of a metabolic approach in the cardiac rehabilitation of patients with coronary artery disease.
Belardinelli R; Lacalaprice F; Faccenda E; Volpe L
Am J Cardiol; 2006 Sep; 98(5A):25J-33J. PubMed ID: 16931203
[TBL] [Abstract][Full Text] [Related]
9. Mechanism(s) of calcium antagonists and ischemia.
Hugenholtz PG; de Jong JW
Z Kardiol; 1984; 73 Suppl 2():89-93. PubMed ID: 6528706
[TBL] [Abstract][Full Text] [Related]
10. [Organic nitrates. I. Mechanism of action and new therapeutic approaches in myocardial ischemia].
Schrör K
Internist (Berl); 1995 Apr; 36(4):392-7. PubMed ID: 7775091
[No Abstract] [Full Text] [Related]
11. [Coronary vasodilators: pharmacological aspect].
Bazaugour R; Evreux JC; Evrard JP
Lyon Med; 1972 Nov; 228(17):427-33. PubMed ID: 4658523
[No Abstract] [Full Text] [Related]
12. Significance of sampling sites in the study of myocardial metabolism in regional ischemia.
Blair E
J Thorac Cardiovasc Surg; 1969 Aug; 58(2):271-8. PubMed ID: 5798231
[No Abstract] [Full Text] [Related]
13. Tracer exchange in the normal and ischemic coronary circulation.
Harris TR; Overholser KA; Collins JC
Fed Proc; 1984 Feb; 43(2):164-70. PubMed ID: 6692935
[TBL] [Abstract][Full Text] [Related]
14. [Energy metabolism in the myocardium with coronary blood flow disorders].
Kübler W; Bretschneider HJ; Grebe D; Orellano LE; Spieckermann PG
Verh Dtsch Ges Kreislaufforsch; 1967; 33():226-31. PubMed ID: 4314362
[No Abstract] [Full Text] [Related]
15. [Amrinone (50 micrograms.kg-1.min-1) does not impair regional myocardial tissue metabolism during the 40%-decrease of left anterior descending coronary flow].
Tateyama T; Suzuki H; Fukuyama H; Fujiwara R; Abe Y; Okutsu Y
Masui; 1996 Feb; 45(2):148-52. PubMed ID: 8865700
[TBL] [Abstract][Full Text] [Related]
16. Metabolic therapy for patients with diabetes mellitus and coronary artery disease.
Rosano GM; Vitale C; Fragasso G
Am J Cardiol; 2006 Sep; 98(5A):14J-18J. PubMed ID: 16931201
[TBL] [Abstract][Full Text] [Related]
17. Importance of investigation of myocardial metabolites in diagnosis and evaluation of treatment of ischaemic heart disease.
Fabián J; Brodan V; Spácil J; Andĕl M
Cor Vasa; 1984; 26(2):88-95. PubMed ID: 6734219
[TBL] [Abstract][Full Text] [Related]
18. [Use of a differential calorimetry method for studying the energy mechanisms of the protective action of anti-ischemic agents].
Artamonov SD; Onishchenko NA
Farmakol Toksikol; 1983; 46(6):88-91. PubMed ID: 6653767
[TBL] [Abstract][Full Text] [Related]
19. [Effects of antioxidant dibunol on central hemodynamics and several parameters of myocardial metabolism in patients with ischemic heart disease].
Vakhliaev VD; Nazarova IM; Barsel' VA; Bogatyrev IV; Tagizade ZA
Kardiologiia; 1990 Sep; 30(9):80-1. PubMed ID: 2273747
[No Abstract] [Full Text] [Related]
20. Properties of prostaglandin E1.
Sinzinger H; Kritz H
Circulation; 1996 Apr; 93(7):1476-7. PubMed ID: 8641045
[No Abstract] [Full Text] [Related]
[Next] [New Search]
